LifeCanvas Technologies Revenue and Competitors
Estimated Revenue & Valuation
- LifeCanvas Technologies's estimated annual revenue is currently $7.6M per year.
- LifeCanvas Technologies's estimated revenue per employee is $155,000
Employee Data
- LifeCanvas Technologies has 49 Employees.
- LifeCanvas Technologies grew their employee count by 53% last year.
LifeCanvas Technologies's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Tissue Processing Products | Reveal Email/Phone |
2 | Senior Microscope Engineer | Reveal Email/Phone |
3 | Senior Application Engineer | Reveal Email/Phone |
4 | Biomedical Engineer | Reveal Email/Phone |
LifeCanvas Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is LifeCanvas Technologies?
LifeCanvas Technologies is an MIT startup with a mission to provide sample-to-answer solutions in biomedical research and clinical diagnosis. Our revolutionary tools and proprietary technologies exclusively licensed by MIT enable studying biological tissues in much greater depth (3D vs. 2D), speed (100x faster), and quality (unlimited labeling markers vs. 2-3) than before, paving the path to fast-track advancements in life sciences and to improve human health.
keywords:N/AN/A
Total Funding
49
Number of Employees
$7.6M
Revenue (est)
53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.6M | 49 | -32% | N/A |
#2 | $3.8M | 49 | -20% | $22.5M |
#3 | $5.7M | 49 | 29% | N/A |
#4 | $3.5M | 49 | 23% | $26.1M |
#5 | $7.6M | 49 | 11% | N/A |